ADC Therapeutics SA is a commercial-stage biotechnology company headquartered in Epalinges, Switzerland. Founded in 2011 as a spin-off, ADC Therapeutics specializes in the development of antibody-drug conjugates (ADCs) for the treatment of hematologic malignancies and solid tumours.
With a workforce of over 270 employees and a strong research focus, ADC Therapeutics continues to advance innovative oncology therapies. As operations scaled, coordinating standard management and analytical standards through manual processes became increasingly challenging, leading the company to adopt AmpleLogic’s Standards Module for digital transformation.
ADC Therapeutics implemented AmpleLogic’s Standards Module to replace paper-based standards and test documentation with a centralized, digital, and validated platform.
The system unified equipment usage logs, reagent data, and analytical test records across departments, ensuring audit readiness and compliance with global data integrity standards. Through digital automation, ADC Therapeutics streamlined its standards with analytics, eliminated redundant manual work, and established real-time visibility into equipment and test performance.
ADC Therapeutics adopted AmpleLogic’s Standards Module, covering multiple categories of reference and analytical standards:
In addition, all analytical data were centralized within a validated digital framework, ensuring complete traceability and data integrity.
ADC Therapeutics selected AmpleLogic for its:
AmpleLogic’s Standards Module provided ADC Therapeutics with a compliant, audit-ready, and scalable digital platform that strengthened data integrity, reduced manual workload, and enhanced operational efficiency across standard management functions.
Ready to Transform Your Standard Management Processes?
Discover how AmpleLogic’s digital solutions can streamline Standards, improve data integrity, and ensure audit-ready documentation.
© 2026 AmpleLogic. All rights reserved.